Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

cfm Inhibitors

Chemical inhibitors of cfm can exert their effects through various pathways, primarily through the modulation of protein kinase C (PKC), which is a critical kinase that influences the function of cfm. Phorbol 12-myristate 13-acetate (PMA) is a known activator of PKC, and through this activation, it can lead to the phosphorylation of cfm, which may result in its inhibition as phosphorylation often regulates protein activity. Conversely, a potent PKC inhibitor like Staurosporine can prevent the phosphorylation of cfm, thereby maintaining it in an inactive state. Similarly, Bisindolylmaleimide I targets PKC for inhibition, potentially leading to decreased cfm activity by limiting its phosphorylation. Gö 6983, which is a pan-PKC inhibitor, can suppress cfm activation by inhibiting the kinase responsible for its activation state. Calphostin C, another PKC inhibitor, prevents the activation of cfm by obstructing the kinase's function.

Continuing with the theme of PKC inhibition, Ro-31-8220, LY333531, and Chelerythrine chloride are all inhibitors of PKC with varying selectivity. Ro-31-8220 is known to inhibit PKC and could therefore reduce cfm activation through decreased phosphorylation. LY333531, which selectively targets PKCβ, can lead to a decrease in cfm activity if cfm is acted upon by this specific isoform of PKC. Chelerythrine chloride's inhibition of PKC can lead to a decrease in cfm function by a similar mechanism of reduced phosphorylation. Sotrastaurin selectively inhibits PKC as well, offering a potential reduction in cfm activity. Gö 6976, with its preference for PKCα and PKCβ, can decrease cfm activity through the same pathway of reduced phosphorylation. Enzastaurin, selective for PKCβ, can inhibit this kinase and thus hinder the phosphorylation and activation processes of cfm, leading to its functional inhibition. Each of these chemicals plays a role in the control of cfm function by targeting the kinases that regulate its activity state through phosphorylation, which is a common regulatory mechanism for protein activity.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates protein kinase C (PKC), which can phosphorylate and thereby inhibit cfm directly or target proteins upstream of cfm influencing its function.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a potent PKC inhibitor, and by inhibiting PKC, it can decrease the phosphorylation status of cfm, leading to its inhibition.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$103.00
$237.00
36
(1)

Bisindolylmaleimide I specifically inhibits PKC, which is required for cfm activity; inhibition of PKC leads to reduced cfm function.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

Gö 6983 is a pan-PKC inhibitor, and by inhibiting this kinase, it can suppress the phosphorylation and activation of cfm.

Calphostin C

121263-19-2sc-3545
sc-3545A
100 µg
1 mg
$336.00
$1642.00
20
(1)

Calphostin C inhibits PKC, and thus can prevent the activation of cfm, leading to its functional inhibition.

Ro 31-8220

138489-18-6sc-200619
sc-200619A
1 mg
5 mg
$90.00
$240.00
17
(1)

Ro-31-8220 inhibits PKC, and by doing so, it can inhibit the phosphorylation and subsequent activation of cfm.

LY-333,531 Hydrochloride

169939-93-9sc-364215
sc-364215A
1 mg
5 mg
$92.00
$281.00
6
(2)

LY333531 is a selective inhibitor of PKCβ, which can decrease cfm activity if cfm is a downstream target of PKCβ.

Chelerythrine chloride

3895-92-9sc-3547
sc-3547A
5 mg
25 mg
$88.00
$311.00
17
(1)

Chelerythrine is a PKC inhibitor, which can lead to a decrease in cfm activity due to reduced phosphorylation and activation.

Sotrastaurin

425637-18-9sc-474229
sc-474229A
5 mg
10 mg
$300.00
$540.00
(0)

Sotrastaurin is a selective inhibitor of PKC, and by inhibiting this kinase, it can reduce cfm activation and function.

Gö 6976

136194-77-9sc-221684
500 µg
$223.00
8
(1)

Gö 6976 preferentially inhibits PKCα and PKCβ, which could decrease cfm activity through reduced phosphorylation.